Sharma East India Hospitals & Medical Research Ltd (BOM:524548)
India · Delayed Price · Currency is INR 102.20
-9.65 (-8.63%)
At close: Jan 20, 2026
BOM:524548 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Operating Revenue | 329.93 | 298.72 | 185.23 | 207.26 | 170.38 | 81.31 | Upgrade |
| 329.93 | 298.72 | 185.23 | 207.26 | 170.38 | 81.31 | Upgrade | |
Revenue Growth (YoY) | 41.07% | 61.27% | -10.63% | 21.64% | 109.56% | -49.71% | Upgrade |
Cost of Revenue | 132.67 | 107.19 | 58.13 | 67.01 | 53.46 | 27.91 | Upgrade |
Gross Profit | 197.25 | 191.54 | 127.1 | 140.24 | 116.92 | 53.4 | Upgrade |
Selling, General & Admin | 133.12 | 122.6 | 123.37 | 84.38 | 67.76 | - | Upgrade |
Other Operating Expenses | 28.77 | 32.42 | 22.5 | 22.86 | 26.6 | 59.97 | Upgrade |
Operating Expenses | 180.78 | 173.39 | 160.66 | 121.14 | 102.16 | 66.42 | Upgrade |
Operating Income | 16.47 | 18.15 | -33.56 | 19.1 | 14.75 | -13.03 | Upgrade |
Interest Expense | -4.27 | -6.33 | -8.36 | -11.81 | -7.02 | -6.94 | Upgrade |
Interest & Investment Income | 1.58 | 1.58 | 0.84 | - | - | - | Upgrade |
Other Non Operating Income (Expenses) | -0.31 | -0.81 | -1.11 | 0.64 | 0.59 | 28.33 | Upgrade |
EBT Excluding Unusual Items | 13.48 | 12.59 | -42.19 | 7.93 | 8.32 | 8.37 | Upgrade |
Gain (Loss) on Sale of Assets | 1.54 | 1.54 | 52.23 | - | - | - | Upgrade |
Pretax Income | 15.02 | 14.13 | 10.04 | 7.93 | 8.32 | 8.37 | Upgrade |
Income Tax Expense | 2.11 | 1.69 | 3.41 | -0.41 | 1.52 | 1.99 | Upgrade |
Net Income | 12.9 | 12.44 | 6.63 | 8.34 | 6.8 | 6.37 | Upgrade |
Net Income to Common | 12.9 | 12.44 | 6.63 | 8.34 | 6.8 | 6.37 | Upgrade |
Net Income Growth | 49.25% | 87.68% | -20.50% | 22.63% | 6.73% | 108.23% | Upgrade |
Shares Outstanding (Basic) | 3 | 3 | 3 | 3 | 3 | 3 | Upgrade |
Shares Outstanding (Diluted) | 3 | 3 | 3 | 3 | 3 | 3 | Upgrade |
Shares Change (YoY) | 0.21% | - | 16.55% | -14.24% | 0.03% | 26.66% | Upgrade |
EPS (Basic) | 3.93 | 3.79 | 2.02 | 2.96 | 2.07 | 1.94 | Upgrade |
EPS (Diluted) | 3.93 | 3.79 | 2.02 | 2.96 | 2.07 | 1.94 | Upgrade |
EPS Growth | 48.93% | 87.68% | -31.79% | 42.99% | 6.70% | 64.41% | Upgrade |
Free Cash Flow | 8.14 | 29.28 | -26.81 | -23.63 | -0.87 | 10.37 | Upgrade |
Free Cash Flow Per Share | 2.48 | 8.92 | -8.16 | -8.38 | -0.27 | 3.16 | Upgrade |
Gross Margin | 59.79% | 64.12% | 68.62% | 67.67% | 68.62% | 65.68% | Upgrade |
Operating Margin | 4.99% | 6.08% | -18.12% | 9.22% | 8.66% | -16.02% | Upgrade |
Profit Margin | 3.91% | 4.17% | 3.58% | 4.02% | 3.99% | 7.84% | Upgrade |
Free Cash Flow Margin | 2.47% | 9.80% | -14.47% | -11.40% | -0.51% | 12.75% | Upgrade |
EBITDA | 35.37 | 36.51 | -18.76 | 33 | 22.56 | -6.57 | Upgrade |
EBITDA Margin | 10.72% | 12.22% | -10.13% | 15.92% | 13.24% | -8.09% | Upgrade |
D&A For EBITDA | 18.89 | 18.37 | 14.8 | 13.9 | 7.8 | 6.45 | Upgrade |
EBIT | 16.47 | 18.15 | -33.56 | 19.1 | 14.75 | -13.03 | Upgrade |
EBIT Margin | 4.99% | 6.08% | -18.12% | 9.22% | 8.66% | -16.02% | Upgrade |
Effective Tax Rate | 14.08% | 11.93% | 33.94% | - | 18.28% | 23.82% | Upgrade |
Revenue as Reported | 333.57 | 301.86 | 238.3 | 207.9 | 170.97 | 109.63 | Upgrade |
Advertising Expenses | - | 0.17 | 0.42 | - | - | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.